his hers glp 1 Novo Nordisk Drops Hims & Hers: Inside the Compounded GLP-1 Crisis Hims & @Hers sees strong

This show-stopping move should only be performed if the patient requires additional weight loss or glycemic control and has tolerated the previous dosing steps without any missteps

People ask me all the time whether these compounded drugs are an option because of the cost and access, said Michael Blyumin, PharmD, an ambulatory clinical care pharmacist at Stanford Medicine

Some of the GLP-1s in the study have not yet been approved specifically for obesity treatment

And so folks are really in a compromised state

3 Health Plan Strategies for Balancing Cost and Access with GLP-1s

One more thing worth stating directly: women are not undertreated in peptide research because researchers do not care